Johnson & Johnson vs Twist Bioscience Corporation
JNJ vs TWST — side-by-side comparison from reported financials. JNJ leads 5, TWST leads 2 of 7 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
Twist Bioscience Corporation
TWST · Healthcare
$161.77+6.39%Strong
| Metric | JNJ | TWST |
|---|---|---|
| Price | $261.79 | $161.77 |
| Market cap | $631B | $10.7B |
| Revenue (TTM) | $97.9B | $432M |
| Revenue growth | +5.6% | +22.8% |
| Net margin | 21.5% | -31.7% |
| Free cash flow | $22.2B | -$93.1M |
| Net cash (debt) | ($27.8B) | — |
| 1-year price return | +37.0% | +407.3% |
| P/E | 29.9 | — |
| P/E vs own history (cheap-side %) | 16% | — |
| Dividend yield | 2.00% | — |
| Return on equity | 26% | -30% |
| Altman Z-score | — | 24.18 |
| CV checks passed | 10 of 11 | 5 of 11 |
| Employees | 140,800 | 979 |
Full résumé-style profiles: JNJ CV · TWST CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.